Fridays Review

Fridays: an all-in-one GLP-1 program that hides its price tag

Fridays (joinfridays.com) is a California-based telehealth company, run out of Irvine, that sells compounded weight-loss injections through a single bundled membership. The pitch is simple: instead of paying separately for a consult, your medication, and check-ins, you pay one program fee and everything is folded in. For people who hate piecing together a GLP-1 plan from multiple invoices, that bundling is genuinely appealing. The catch is just as simple — Fridays does not publish a clear, standard monthly rate in the places we verify, so you can't actually compare it to anyone else until you're partway through the signup flow.

How the Fridays program is built

Fridays describes its membership as everything-included. According to the company's own pricing page, 'medication costs are included in the Fridays program,' you get 'unlimited provider visits,' and every plan bundles 'comprehensive coaching.' In plain terms, the drug, the clinician access, and the behavioral support are meant to live under one fee rather than as add-ons. That's a meaningfully different structure from providers who quote you a low medication price and then layer on a separate visit or membership charge.

What's included, based on the verified record:

• Medication baked into the program fee — no separate pharmacy line item
• Unlimited provider visits, so dose changes and questions don't cost extra
• Coaching included with every plan for the lifestyle side of weight loss
• No lab fees — though note this means labs aren't billed separately, not that bloodwork is provided for you

The medications: compounded semaglutide and tirzepatide

Fridays offers both major GLP-1 molecules in compounded form: semaglutide, the drug in Ozempic and Wegovy, and tirzepatide, the dual-action molecule in Mounjaro and Zepbound. Having both on the menu is a real plus — many budget telehealth shops only carry compounded semaglutide, so if your clinician thinks tirzepatide is the better fit, you'd otherwise have to switch providers. Because these are compounded versions (mixed by a pharmacy rather than mass-produced by the brand manufacturer), they are not FDA-approved finished products, and the usual compounded-GLP-1 trade-offs apply: lower cost, but a formulation that hasn't gone through the same approval process as the branded pen.

What sets Fridays apart — and the honest caveat

The real differentiator here is the all-inclusive, low-friction membership: one fee, unlimited visits, medication and coaching bundled, and no surprise lab billing. For a first-time GLP-1 patient who just wants a single number and a single point of contact, that's a clean experience.

But two things keep us cautious. First, Fridays does not publicly disclose its state availability. The verified record notes that prescriptions are 'not guaranteed and depend on provider discretion,' so whether you can actually get treatment depends on where you live and what the clinician decides — you may go through intake and still not receive a script. Second, and most importantly for shoppers, the standard monthly price isn't published in our structured data. By contrast, the typical compounded GLP-1 program in our database runs around $170 a month, which gives you a yardstick — but you should confirm Fridays' actual figure directly before you commit, because we can't verify a fixed rate for it.

Who should pick Fridays — and who shouldn't

Fridays makes sense if you value a bundled, no-add-ons experience and want both semaglutide and tirzepatide on the table. The unlimited-visits model is especially useful early on, when you're titrating up and may need to message your provider often without watching a meter run.

Skip it, or at least shop around first, if you fall into any of these camps:

• You want price transparency up front — Fridays doesn't post a clear standard rate, so you can't compare apples to apples before signing up
• You need a guaranteed prescription — approval is at provider discretion and isn't promised
• You need to confirm coverage in your state — the available-states list isn't public, so check before you invest time in intake
• You want brand-name pens or insurance billing — this is a cash-pay, compounded-medication program

Trust and medical oversight

On the safety ledger, there are no FDA warning letters on file for Fridays, which is a point in its favor — some compounded-GLP-1 sellers do carry them. The flip side is thin public detail: there's no named, accredited compounding pharmacy partner in the verified record, and no disclosed state footprint. That doesn't mean anything is wrong, but it does mean you're taking more on faith than you would with a provider that names its pharmacy and lists its licensure openly. For how we weigh disclosure, accreditation, and FDA status, see our scoring methodology.

Bottom line

Fridays is a reasonable mainstream option for bundled, low-hassle access to compounded semaglutide or tirzepatide, with unlimited provider visits and coaching rolled into one fee. The experience is built to be easy. The problem is what you can't see before you commit: no published standard price, no public state list, and no named pharmacy partner. If you're comfortable confirming the monthly cost and your state eligibility directly with the company — and you like the idea of one all-inclusive fee — Fridays is worth a look. If you want everything spelled out before you hand over a card, a more transparent provider will serve you better.

If you're weighing alternatives, Telos Rx ($49/month) and bmiMD ($99/month) are among the closest options we track to Fridays.